“…The inclusion criteria were as follows: (1) skin biopsy indicating intranuclear inclusions in the nuclei of fibroblasts, fat cells and ductal epithelial cells of sweat glands, (2) NOTCH2NLC gene testing showing abnormal repeated GGC premutation, and (3) detailed medical history. Finally, 63 patients met the inclusion criteria ( Chen et al, 2020 ; Dong et al, 2020 ; Guo et al, 2020 ; Ishihara et al, 2020 ; Li et al, 2020 ; Liang et al, 2020 ; Ogasawara et al, 2020 ; Okamura et al, 2020 ; Wang et al, 2020 ; Yuan et al, 2020 ; Zhang et al, 2020 , 2022 ; Cao et al, 2021 ; Deng et al, 2021 ; Huang et al, 2021 ; Kikumoto et al, 2021 ; Kotani et al, 2021 ; Pang et al, 2021 ; Tachi et al, 2021 ; Zhao et al, 2021 ; Liao et al, 2022 ; Yang et al, 2022 ). The clinical, radiological, pathological, genetic, electrophysiological features, and cerebrospinal fluid (CSF) results were analyzed.…”